Health Care & Life Sciences » Biotechnology | RegeneRX Biopharmaceuticals Inc.

RegeneRX Biopharmaceuticals Inc. | Ownership

Companies that own RegeneRX Biopharmaceuticals Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Williams, Jones & Associates LLC
150,000
0.12%
0
0%
06/30/2018
Dumont & Blake Investment Advisors LLC
22,300
0.02%
0
0%
06/30/2018
Invesco Capital Management LLC
17,879
0.02%
0
0%
09/05/2018

About RegeneRX Biopharmaceuticals

View Profile
Address
15245 Shady Grove Road
Rockville Maryland 20850
United States
Employees -
Website http://www.regenerx.com
Updated 07/08/2019
RegeneRx Biopharmaceuticals, Inc. operates as a biopharmaceutical company focused on the development of a novel therapeutic peptide, Thymosin beta 4, or Tß4, for tissue and organ protection, repair, and regeneration. The firm evaluates the commercial development of peptide fragments and derivatives of Tß4 for potential cosmeceutical and other personal care uses. Its products include RGN-259, RGN-352, and RGN-137.